Treatment With Ezetimibe in Kidney Transplant Recipients With Uncontrolled Dyslipidemia

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 2925-2926

  Lopez V ^a   Gutierrez C ^a   Gutierrez E ^a   Sola, E ^a   Cabello, M ^a   Burgos, D ^a   Gonzalez Molina M ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CREATINE KINASE; CYCLOSPORIN; EZETIMIBE; LACTOSE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDOREDUCTASE; PRAVASTATIN; PREDNISONE; RAPAMYCIN; SIMVASTATIN; TACROLIMUS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CARDIOVASCULAR DISEASES; CHOLESTEROL; CREATINE KINASE; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; L-LACTATE DEHYDROGENASE; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 55749115955     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.09.046     Document Type: Article

References (7)

1. Bostom A.D., Brown R.S.J., and Chavers B.M. Prevention of post-transplant cardiovascular disease. Report and recommendations of Ad Hoc Group. Am J Transplant 2 (2002) 491
2. Bumgardner G.L., Wilson G.A., and Tso P.L. Impact of serum lipids on long-term graft and patient survival after renal transplantation. Transplantation 60 (1995) 1418
3. Pearson T.A., Blair S., and Bonow R. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106 (2002) 388
4. Puthenparumpil J., Keough-Ryan T., and Kibed M. Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population. Transplant Proc 37 (2005) 1033
5. Buchanan C., Smith L., and Corbett J. A retrospective analysis of ezetimibe treatment in renal transplant recipients. Am J Transplant 6 (2006) 770
6. Turk T., Voropaeva E., and Kohnle M. Ezetimibe treatment in hypercholesterolaemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study. Nephrol Dial Transplant 23 (2008) 369
7. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative (NKF K/DOQI) Clinical Practice Guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 41 suppl 3 (2003) S1